Results 181 to 190 of about 32,832 (202)

FGFR inhibitors for advanced cholangiocarcinoma

The Lancet Oncology, 2020
Tian, Yang, Lei, Liang, Ming-Da, Wang, Feng, Shen   +3 more
openaire   +2 more sources

FIGHT-101, a first-in-human study of potent and selective FGFR 1-3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies

Annals of Oncology, 2022
Vivek Subbiah, D C Smith, T Ji
exaly  

Biological Significance and Targeting of the FGFR Axis in Cancer

Cancers, 2021
Athina-Myrto Chioni, Richard P Grose, Grose Richard P   +2 more
exaly  

FGFR Inhibitors in Oncology: Insight on the Management of Toxicities in Clinical Practice

Cancers, 2021
Anuhya Kommalapati, Mitesh J Borad, Milind Javle   +2 more
exaly  

Recent advances of dual FGFR inhibitors as a novel therapy for cancer

European Journal of Medicinal Chemistry, 2021
Jun Hou, Yonghe Hu, Jianyou Shi
exaly  

FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention

Cancers, 2021
Yijun Wang, Liu Danfei, Tongyue Zhang
exaly  

FGFR-1

1998
Tak W. Mak, Josef Penninger, John Roder, Janet Rossant, Mary Saunders   +4 more
openaire   +1 more source

FGFR Mutation in Pfeiffer Syndrome

Journal of Craniofacial Surgery, 2013
openaire   +2 more sources

Prevention and treatment of FGFR inhibitor-associated toxicities

Critical Reviews in Oncology/Hematology, 2020
Amit Mahipal, Anuhya Kommalapati, James Yu   +2 more
exaly  

FGFR a promising druggable target in cancer: Molecular biology and new drugs

Critical Reviews in Oncology/Hematology, 2017
Shahanavaj Khan, Antonio Araujo, Tindara Franchina   +2 more
exaly